Helena Paidassi

Helena Paidassi

Auto-generated profile, based on publicly available information

Helena Paidassi

CIRI, Centre International de Recherche en Infectiologie, Université de Lyon, Inserm U1111, Université Claude Bernard Lyon 1, CNRS UMR5308, ENS de Lyon, Lyon, France

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2008 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
HPHelena Païdassi
Helena Païdassi
PTPascale Tacnet-Delorme
Pascale Tacnet-Delorme
VGVirginie Garlatti
Virginie Garlatti
CDClaudine Darnault
Claudine Darnault
BGBerhane Ghebrehiwet
Berhane Ghebrehiwet
PFPhilippe Frachet
Philippe Frachet
Efficient apoptotic cell clearance is critical for maintenance of tissue homeostasis, and to control the immune responses mediated by phagocytes. Little is known about the molecules that contribute “eat me” signals on the apoptotic cell surface. C1q, the recognition unit of the C1 complex of complement, also senses altered structures from self and is a major actor of immune tolerance. HeLa cells were rendered apoptotic by UV-B treatment and a variety of cellular and molecular approaches were used to investigate the nature of the target(s) recognized by C1q. Using surface plasmon resonance, C1q binding was shown to occur at early stages of apoptosis and to involve recognition of a cell membrane component. C1q binding and phosphatidylserine (PS) exposure, as measured by annexin V labeling, proceeded concomitantly, and annexin V inhibited C1q binding in a dose-dependent manner. As shown by cosedimentation, surface plasmon resonance, and x-ray crystallographic analyses, C1q recognized PS specifically and avidly (KD = 3.7–7 × 10−8 M), through multiple interactions between its globular domain and the phosphoserine group of PS. Confocal microscopy revealed that the majority of the C1q molecules were distributed in membrane patches where they colocalized with PS. In summary, PS is one of the C1q ligands on apoptotic cells, and C1q-PS interaction takes place at early stages of apoptosis, in newly organized membrane patches. Given its versatile recognition properties, these data suggest that C1q has the unique ability to sense different markers which collectively would provide strong eat me signals, thereby allowing efficient apoptotic cell removal.

25 November 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
AKAlice Koenig
Alice Koenig
CCChien-Chia Chen
Chien-Chia Chen
AMAntoine Marçais
Antoine Marçais
TBThomas Barba
Thomas Barba
VMVirginie Mathias
Virginie Mathias
OTOlivier Thaunat
Olivier Thaunat
Current doctrine is that microvascular inflammation (MVI) triggered by a transplant -recipient antibody response against alloantigens (antibody-mediated rejection) is the main cause of graft failure. Here, we show that histological lesions are not mediated by antibodies in approximately half the participants in a cohort of 129 renal recipients with MVI on graft biopsy. Genetic analysis of these patients shows a higher prevalence of mismatches between donor HLA I and recipient inhibitory killer cell immunoglobulin-like receptors (KIRs). Human in vitro models and transplantation of β2-microglobulin-deficient hearts into wild-type mice demonstrates that the inability of graft endothelial cells to provide HLA I-mediated inhibitory signals to recipient circulating NK cells triggers their activation, which in turn promotes endothelial damage. Missing self-induced NK cell activation is mTORC1-dependent and the mTOR inhibitor rapamycin can prevent the development of this type of chronic vascular rejection.

9 March 2011 in RNA
Verified
Journal Article
Open access
PDF file
GNGabriele Neu-Yilik
Gabriele Neu-Yilik
BABeate Amthor
Beate Amthor
NGNiels H. Gehring
Niels H. Gehring
SBSharif Bahri
Sharif Bahri
HPHelena Paidassi
Helena Paidassi
AKAndreas E. Kulozik
Andreas E. Kulozik
The degradation of nonsense-mutated β-globin mRNA by nonsense-mediated mRNA decay (NMD) limits the synthesis of C-terminally truncated dominant negative β-globin chains and thus protects the majority of heterozygotes from symptomatic β-thalassemia. β-globin mRNAs with nonsense mutations in the first exon are known to bypass NMD, although current mechanistic models predict that such mutations should activate NMD. A systematic analysis of this enigma reveals that (1) β-globin exon 1 is bisected by a sharp border that separates NMD-activating from NMD-bypassing nonsense mutations and (2) the ability to bypass NMD depends on the ability to reinitiate translation at a downstream start codon. The data presented here thus reconcile the current mechanistic understanding of NMD with the observed failure of a class of nonsense mutations to activate this important mRNA quality-control pathway. Furthermore, our data uncover a reason why the position of a nonsense mutation alone does not suffice to predict the fate of the affected mRNA and its effect on protein expression.

28 October 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
ALAlexandra Lainé
Alexandra Lainé
OLOssama Labiad
Ossama Labiad
HHHector Hernandez-Vargas
Hector Hernandez-Vargas
STSébastien This
Sébastien This
ASAmélien Sanlaville
Amélien Sanlaville
JMJulien C. Marie
Julien C. Marie
Presence of TGFβ in the tumor microenvironment is one of the most relevant cancer immune-escape mechanisms. TGFβ is secreted in an inactive form, and its activation within the tumor may depend on different cell types and mechanisms than its production. Here we show in mouse melanoma and breast cancer models that regulatory T (Treg) cells expressing the β8 chain of αvβ8 integrin (Itgβ8) are the main cell type in the tumors that activates TGFβ, produced by the cancer cells and stored in the tumor micro-environment. Itgβ8 ablation in Treg cells impairs TGFβ signalling in intra-tumoral T lymphocytes but not in the tumor draining lymph nodes. Successively, the effector function of tumor infiltrating CD8+ T lymphocytes strengthens, leading to efficient control of tumor growth. In cancer patients, anti-Itgβ8 antibody treatment elicits similar improved cytotoxic T cell activation. Thus, this study reveals that Treg cells work in concert with cancer cells to produce bioactive-TGFβ and to create an immunosuppressive micro-environment.

1 November 2011 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
HPHelena Païdassi
Helena Païdassi
MAMridu Acharya
Mridu Acharya
AZAiliang Zhang
Ailiang Zhang
SMSubhankar Mukhopadhyay
Subhankar Mukhopadhyay
MKManjae Kwon
Manjae Kwon
ALAdam Lacy–Hulbert
Adam Lacy–Hulbert

1 April 2011 in Journal of Molecular Biology
Verified
Journal Article
Closed access
HPHelena Païdassi
Helena Païdassi
PTPascale Tacnet-Delorme
Pascale Tacnet-Delorme
MVMélanie Verneret
Mélanie Verneret
CGChristine Gaboriaud
Christine Gaboriaud
GHGunnar Houen
Gunnar Houen
PFPhilippe Frachet
Philippe Frachet